DCF Advisers’s Zai Lab ZLAB Stock Holding History

DCF Advisers’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,500	Closed	-$26.5K	–	107
2025 Q4	$26.5K	Buy	+1,500	New	+$35.1K	0.01%	95

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

DCF Advisers's ZLAB Position: Q2 2026 in Review

DCF Advisers held its Zai Lab (ZLAB) position steady in Q2 2026 at 63,500 shares worth $1.21M. The position accounts for 0.21% of the portfolio, ranked #60.

DCF Advisers first reported a position in ZLAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.25M in Q1 2025. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

DCF Advisers held 63,500 shares of Zai Lab worth $1.21M as of Q2 2026.
DCF Advisers left its Zai Lab share count unchanged in Q2 2026.
Zai Lab made up 0.21% of DCF Advisers's portfolio in Q2 2026, its #60 holding.
DCF Advisers first reported a position in Zai Lab in Q2 2024 and has held it in 9 quarters since.
DCF Advisers's Zai Lab position peaked at $3.25M in Q1 2025.
92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.